Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.

about

ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass.Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder TGF-Beta Signaling in Bone with Chronic Kidney Disease

P2860

Q45219853-DAE7AEDD-AE5B-425E-AE52-3CA1ED2C869C Q58710472-D3FE8B9A-518D-4AC2-9519-EC7612C5CB1F Q58789309-0D90F90E-D495-4D0E-B3CE-2A0E438E293E

P2860

Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.

Item

http://www.wikidata.org/entity/Q41146384

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Ligand trap of the activin rec ...... e with chronic kidney disease.

@en

type

Item

label

Ligand trap of the activin rec ...... e with chronic kidney disease.

@en

prefLabel

Ligand trap of the activin rec ...... e with chronic kidney disease.

@en

P1476

Ligand trap of the activin rec ...... e with chronic kidney disease.

@en

P2093

Alycia G Berman

http://www.w3.org/2001/XMLSchema#string

Hartmut H Malluche

http://www.w3.org/2001/XMLSchema#string

Keith A Hruska

http://www.w3.org/2001/XMLSchema#string

Marie-Claude Faugere

http://www.w3.org/2001/XMLSchema#string

Olga A Agapova

http://www.w3.org/2001/XMLSchema#string

Toshifumi Sugatani

http://www.w3.org/2001/XMLSchema#string

Victoria Sung

http://www.w3.org/2001/XMLSchema#string

William Smith

http://www.w3.org/2001/XMLSchema#string

Yifu Fang

http://www.w3.org/2001/XMLSchema#string

P2860

Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures.

Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy

Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

ActRIIA and BMPRII Type II BMP receptor subunits selectively required for Smad4-independent BMP7-evoked chemotaxis

Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.

Klotho deficiency causes vascular calcification in chronic kidney disease.

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy.

P304

86-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.KINT.2016.07.039

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joseph M. Wallace

P577

2016-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27666759

http://www.w3.org/2001/XMLSchema#string

P921

signaling

P932

5530394

http://www.w3.org/2001/XMLSchema#string

Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.

about

P2860

P2860

Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932